top of page

Recent Posts

Archive

Tags

Positron Emission Tomography /Computed Tomography Follow-Up in Patients with Gastrointestinal Tract.

Background: PET/CT is becoming more widely used in oncology, including GIT.PET/CT plays a bigger part in followup than it does in initial staging and diagnosis since it assists with therapy evaluation and detects recurrence and metastasis. It aids in the detection of distant metastasis and the discovery of synchronous neoplasm in esophageal cancer.It is also praised for assisting in the early identification of a patient's reaction to chemo and radiotherapy. It could be useful to detect recurrence in the follow-up.

PET/CT has a minor function in gastric cancer because it does not outperform CT alone. PET/CT scans are useful in cases of suspected liver or lung metastasis of colorectal cancer.

During operation, there was a local recurrence.

The aim of this research was to see how PET/CT affected treatment decisions and follow-up in patients with gastrointestinal malignancies. The data and records of 47 GIT malignancy patients who received PET/CT during or after treatment were collected retrospectively in this cross-sectional analysis.

Between July 2015 and December 2017, I worked at Tanta University's PET/CT unit in the Diagnostic Radiology Department of Educational Hospitals.The patients were mostly colorectal cancer patients with adenocarcinoma as the primary cancer form. We discovered that the PET/CT findings affected the treatment plans of 27.7% of patients; the percentage is highest for colon cancer (40%) followed by rectal cancer (25%) and our few esophageal, gastric, and intestinal malignancies cases showed no impact due to a limited number of cases. With a 66.7 percent shift in care plans, PET/CT appears to have the highest add benefit in patients with colorectal cancer who have metastasized. Due to scan limitations, six patients' PET/CT findings were inconclusive. Conclusion: In the case of esophageal or gastric cancer, relying on PET/CT in clinical decisions is not recommended unless there is a clinical or imaging suspicion of recurrence. PET/CT, on the other hand, is useful in detecting colorectal cancer post-treatment metastasis and local recurrence.

Comments

bottom of page